Navigation Links
Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research
Date:7/31/2014

Increased healthcare awareness and well established healthcare infrastructure have also contributed towards the deployment and installation of latest and technological advancements have contributed towards higher sales of the electrodes and associated devices. During the forecasted period the Asia-Pacific market is expected to be the fasted growing market. Some of the factors contributing the growth for this market include rise in disposable income, escalated government intervention to reform healthcare facilities and infrastructure developments. In addition, growing trend for medical tourism in this region also uplifts the market for medical device electrodes.

The global electrodes market is highly fragmented with the presence of well established as well as emerging market players. Some of the prominent players in the medical device electrodes market include 3M Company, Ambu A/S, CONMED Corporation, Philips Healthcare Medtronic, Inc., and Natus Medical, Inc. among others.

Related & Recently Published Reports by Transparency Market Research 


The global electrodes for medical devices market is segmented as follows:

  • Diagnostic Electrodes for Medical Devices Market, by Diagno
    '/>"/>

SOURCE Transparency Market Research
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. New options for transparent contact electrodes
2. Silicon-carbon electrodes snap, swell, dont pop
3. UCLA team develops highly efficient method for creating flexible, transparent electrodes
4. Sequenom Enters Into License Agreement With Mayo Medical Laboratories
5. Clinovo White Papers Published in Summer 2014 Editions of Leading Medical Device & Pharmaceutical Publications
6. MSC and Cape Regional Medical Center Partner to Improve Cost, Quality and Outcomes
7. GrowBLOX Sciences, Inc. Files for Two Additional Medical Marijuana Dispensaries in Las Vegas
8. Dr. Neal Rouzier Joins BioTE Medical
9. Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery
10. Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally
11. Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague”
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... CA (PRWEB) , ... July 01, 2015 , ... It ... brain injury (TBI) using single photon emission computed tomography (SPECT) according to ... The study, which examined over 20,000 brain scans and is believed to be the ...
(Date:7/1/2015)... July 1, 2015   Neuraltus Pharmaceuticals, Inc. ... of groundbreaking drugs to treat neurodegenerative diseases such ... Robert G. Miller , M.D., Director of the ... California Pacific Medical Center in San Francisco, has been ... $1.5 million to help fund a Phase 2 ...
(Date:7/1/2015)... ... July 01, 2015 , ... Apex Therapeutics announced today ... Convention in Philadelphia, PA. , The presentation took place on Tuesday, June ... plans for the development of APX3330 for the treatment of pancreatic cancer. A ...
(Date:6/30/2015)... 30, 2015 /PRNewswire/ - Resverlogix Corp. ("Resverlogix") (TSX:RVX) ... of Resverlogix have approved the resolutions relating to: ... of 5,600,000 units at a price of $2.67 ... being comprised of one common share and 0.075358 ... approximately CAD$15 million; and (ii) the amendment to ...
Breaking Biology Technology:Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 4Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Apex Therapeutics Presented Company Overview at This Year’s BIO International Convention in Philadelphia, PA 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3
... Speid & Associates, an international regulatory and drug ... entered into a partnership with Genizon BioSciences to ... Genizon,s proprietary genetic platform. In this challenging ... companies have to watch every dollar that is ...
... bio-manufacturing process to produce methyl ethyl ketone from ... 25 Researchers at Genomatica, Inc., a sustainable ... methyl ethyl ketone (MEK), a commonly used industrial ... than $2 billion. The rapid development breakthrough ...
... Therapeutics,(Nasdaq: NKTR ) today reported its ... December 31, 2008. , ... Howard W. Robin,President and Chief Executive Officer of ... we advanced numerous proprietary drug,candidates into clinical and ...
Cached Biology Technology:Speid & Associates Partners With Genizon BioSciences to Reduce Attrition Rates of New Drug Compounds 2New Genomatica Chemical Process Targets Ailing Ethanol Assets 2New Genomatica Chemical Process Targets Ailing Ethanol Assets 3New Genomatica Chemical Process Targets Ailing Ethanol Assets 4New Genomatica Chemical Process Targets Ailing Ethanol Assets 5Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results 2Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results 3Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results 4Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results 5Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results 6Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results 7Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results 8Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results 9
(Date:6/11/2015)... , June 11, 2015 Daon, ... announced today that its IdentityX Mobile Authentication Platform ... IDentity Online) Alliance is an industry consortium launched ... standards for simpler, stronger authentication.  In order to ... pass a rigorous series of tests that measure ...
(Date:6/9/2015)... June 9, 2015   MedNet Solutions , an ... spectrum of clinical research, will be providing demonstrations of ... at the 2015 Drug Information Association (DIA) Annual Meeting ... 15-17.  These presentations will include previews of many exciting ... the upcoming iMedNet 2015 Feature 1 Release. ...
(Date:6/8/2015)... 2015  Trovagene, Inc. (NASDAQ: TROV ), a developer ... its Precision Cancer Monitoring SM platform will be presented ... in San Diego, CA on June ... Integrating Clinical Genomics and Cancer Therapy in ... "We continue to advance our clinical programs and ...
Breaking Biology News(10 mins):Daon's IdentityX Mobile Authentication Platform One of First Products to be Certified by FIDO Alliance 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 3Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 2Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 3Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 4
... Ind. - Discovery that a specific gene is integral to ... deadly toxin in the kernels may lead to ways to ... evaluated the fungal gene ZFR1 and found that it is ... kernels. Production of the toxin decreased when the scientists disabled ...
... Simplifying the process for forming compounds that can be ... plastics, has earned one University of Houston chemist a ... of chemistry in the College of Natural Sciences and ... mathematicians and economists in the United States and Canada ...
... Bioscience Horizons, a unique peer-reviewed journal comprising entirely of ... and Republic of Ireland. Bioscience Horizons ( ... the universities of Leeds, Nottingham, Reading, Chester and Trinity ... forum for the brightest undergraduates in the UK and ...
Cached Biology News:Defining gene's role may lead to prevention of dangerous corn toxin 2Defining gene's role may lead to prevention of dangerous corn toxin 3Simplifying manufacture of drugs, plastics earns UH chemist top honor 2
... The binding specificity and signaling of ... known to be modified by alternative splicing--which ... GPCR SpliceArrays you can perform a classical ... detect the different alternatively spliced forms of ...
... sensitivity of DNA detection has been improved. With ... agarose gel can be detected > 20 ng. ... purified by organic solvent extraction or with other ... well.) DNA excised from agarose gel can ...
Mouse monoclonal antibody raised against a partial recombinant ST3GAL2. NCBI Entrez Gene ID = ST3GAL2...
... Serum-free adapted Sf9 derivative for high-yield ... Sf9 Cells are derived from a high-yielding ... in Novagen serum-free TriEx Insect Cell Medium, ... and protein yields by either baculovirus infection ...
Biology Products: